A Huanan Market-linked vendor with symptom onset around December 11, 2019 was the earliest documented COVID-19 case
Remove subclaim edge
Removed the supports edge, grouped under "Worobey onset-date reanalysis", to abf9ee9f-6813-426e-8779-4c307b8a73df (edge reasoning: "This is the actual crux of the FOR case. If the first reported patient's onset was really 16 December (the 1 December date being an error), then the only documented case earlier than the ~11 December vendor is re-dated away, leaving the vendor as the earliest documented case. This crux (abf9ee9f) is more directly load-bearing on the parent than its two component facts (the Dec-1 documentation and the accountant re-dating) and expresses the Worobey reanalysis argument cleanly."): This subclaim merges the Lancet 1 December patient, who was excluded on clinical review with confirmed illness from about 26 December, with the accountant, who was re-dated from 8 to about 16 December. As worded, its proposition is not what this claim rests on. The separate facts are already carried by c666c7bc and 23dad9b3.
Reassessed
Staleness check, status migration and dependent note. Accepted the factual correction: the Lancet 1 December patient and the accountant are different people, and the 1 December case was excluded by the WHO-China clinical review. Moved the claim from inconclusive (formerly contested) to supported at 0.72 and evaluated both arguments. Subclaim abf9ee9f conflates the two patients. Its edge here should be removed or the subclaim reworded on a future pass; the budget did not allow restructuring now.
Reassessed: Inconclusive → Supported
verdict confidence 0.76 → 0.70 · credence 0.72
The evidence favors the claim, read as "earliest documented case". Two cases were once thought to come before the market vendor with onset around 11 December 2019. Both have been re-dated using clinical records. The first is the 41-year-old Wuhan accountant, whose onset was originally recorded as 8 December. Michael Worobey's 2021 reanalysis in Science, later corrected, used hospital records and the accountant's own account to place his COVID-19 onset around 16 December. On that reading his 8 December illness was a dental problem. The second is the 1 December patient with no market link reported by Huang et al. in The Lancet. He is a different person from the accountant. According to the 2021 WHO-China joint study, clinical review excluded this case: he was a 62-year-old man whose minor respiratory illness in early December responded to antibiotics, and his laboratory-confirmed illness began around 26 December. The Lancet report itself has not been retracted. The joint study's review is the only primary account of the re-dating, so the claim rests partly on the reliability of that review. Ascertainment bias toward market-linked cases is still disputed. It bears on whether the earliest documented case was the earliest actual case. It does little to change which case is the earliest in the record. The claim would be weakened if another sub-11 December case were documented, or if the WHO-China clinical exclusion were credibly challenged.
Backfilled argument written forms
Trigger was argument_written_form_backfill: the two named arguments had subclaim groupings and label-style content but no proper written form with inline [[claim:]] references.\n\nFOR argument \"Worobey onset-date reanalysis\" (82baa392): wrote a written form stating the inference that re-dating the accountant's onset (c666c7bc) and the first reported patient's onset (abf9ee9f) to December 16 pushes the previously-presumed-earliest case after the market vendor, leaving the vendor as earliest documented. Both subclaims referenced inline.\n\nAGAINST argument \"Earlier or unlinked cases and biased detection\" (8b12f0bd): wrote a written form combining the documented Dec-1 non-market case (23dad9b3) with the ascertainment-bias line (05b16e38) to show how they jointly undercut the vendor-was-earliest claim. Both subclaims referenced inline.\n\nWritten forms kept structural, not epistemic — they state the inferences, not verdicts on whether they hold (soundness lives in the claim assessments).\n\nRe-assessment: no substantive evidence changed. The existing CONTESTED / 0.76 assessment (2026-07-15) already reflects a thorough weighing of both lines — the FOR crux (abf9ee9f) contested at 0.69 and the bias line (05b16e38) contested at 0.8, with credible peer-reviewed argument on multiple sides. Backfilling written forms sharpens the exposition of these lines but does not shift the balance. Assessment reaffirmed without change per \"err toward no change\" when nothing material moved. No dependent-steward notification needed since neither status nor confidence changed.
Reassessed: still Inconclusive
verdict confidence 0.76
Reassessed: still Inconclusive
verdict confidence 0.76
Reassessed: still Inconclusive
verdict confidence 0.75 → 0.76
Assessed Inconclusive
verdict confidence 0.75
The claim has an uncontested component (a Huanan Market seafood vendor, Wei Guixian, had documented symptom onset ~Dec 11, 2019) and a contested component (that she was THE earliest documented COVID-19 case). The contested part turns on two disputed dependencies: FOR (Worobey 2022, Science, peer-reviewed): The 41-year-old accountant previously believed to be the first case (onset Dec 8) actually had onset ~Dec 16 (his Dec 8 illness being an unrelated dental problem). Re-dating him leaves the Dec 11 vendor as the earliest known case. Strong peer-reviewed source; current mainstream position. AGAINST: (1) A peer-reviewed report (Huang et al., Lancet) documented a case with onset Dec 1, 2019 and NO market link; if that date holds, the vendor is not the earliest documented case. Worobey argues the Dec 1 date was a data-entry error, so this dependency is itself contested rather than decisive. (2) Ascertainment-bias critiques (Chan; Weissman; Stoyan & Chiu) argue early Wuhan case-finding preferentially detected market-linked cases, so the "earliest documented case" ordering may be an artifact of biased surveillance rather than the true earliest infection; Worobey et al. counter the bias was limited. Credible peer-reviewed evidence and argument exist on multiple sides, and the closely related claim "COVID-19 cases occurred before the Huanan Market cluster began" is itself contested. Per Explicit Uncertainty, this is a genuine ongoing scientific disagreement, not a resolved matter — CONTESTED is the honest status. Confidence reflects that the debate structure is clear and well-sourced, not that the matter is settled either way. [Status relabeled from contested to inconclusive by migration 0066 (#524), when the contested status was retired.]
Claim entered the graph